Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F13%3A43907655" target="_blank" >RIV/00216208:11120/13:43907655 - isvavai.cz</a>

Alternative codes found

RIV/00064173:_____/13:N0000004

Result on the web

<a href="http://dx.doi.org/10.1111/joic.12051" target="_blank" >http://dx.doi.org/10.1111/joic.12051</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/joic.12051" target="_blank" >10.1111/joic.12051</a>

Result language

angličtina

Original language name

Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study

Original language description

We evaluated the safety and effectiveness of the Resolute zotarolimus-eluting stent (R-ZES) in real-world clinical practice through 3 years. A randomized comparison of the R-ZES and the XIENCE V everolimus-eluting stent showed no difference in any outcomes through 3-year follow-up in high-volume academic centers. RESOLUTE International is a confirmatory trial designed to evaluate the R-ZES in real-world clinical practice. RESOLUTE International is a single arm, observational trial that enrolled 2,349 patients from 88 centers with only a few inclusion and exclusion criteria. The primary end-point was the composite of cardiac death and target vessel myocardial infarction (TV-MI) at 1 year. Secondary end-points include target lesion failure (TLF), targetvessel revascularization (TVR), and their components, and stent thrombosis (ST). At 3 years 97.2% of patients completed clinical follow-up. The mean age was 63.411.2 years, 77.8% were male, and 30.4% had diabetes. The average number of st

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Journal of Interventional Cardiology

ISSN

0896-4327

e-ISSN

—

Volume of the periodical

26

Issue of the periodical within the volume

5

Country of publishing house

GB - UNITED KINGDOM

Number of pages

9

Pages from-to

515-523

UT code for WoS article

000325478600011

EID of the result in the Scopus database

—